Anzeige
Mehr »
Montag, 27.10.2025 - Börsentäglich über 12.000 News
Automatisierung ist das neue Gold: Telescope Innovations erfindet Entdeckung von Medizin & Materialien neu!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Private Equity Wire

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
07.10.Portage Point Partners appoints MD for OCFO Practice
07.10.Blackstone and Lunate launch $5bn Gulf logistics investment platform
07.10.Bain Capital closes fourteenth flagship PE fund at $14bn
06.10.EQT nominates Salata as next Chair
06.10.Aurelius weighs sale of LSG Group's Asia Pacific catering unit
06.10.August Equity holds final close of Fund VI at £350m hard cap
06.10.US watchdog to probe risks in $1.7tn private credit market
06.10.CVC to acquire Bamboo insurance platform from White Mountains in $1.75bn deal
06.10.From entry to exit: How smart IT teams safeguard enterprise value
03.10.Sriwijaya Capital raises $200m for debut fund, targets $300m hard cap
03.10.Regulation remains a concern for North American PE and VC firms
03.10.Arena Investors to close Singapore office
03.10.Stephenson Harwood appoints new Partner
03.10.Oxane targets $45tn 'Private Credit+' market
03.10.Emerald Lake adds two to investment team
03.10.Catchment Capital makes inaugural investment in Fidus Systems
03.10.PAI Partners secures €3.6bn for Nestlé ice cream JV Froneri
03.10.Blackstone raises $10bn for Asia buyout fund
02.10.KKR expands Middle East presence with minority gas pipeline stake
02.10.Brookfield eyes $12.5bn for seventh flagship PE fund
02.10.Apollo and Vistria-backed University of Phoenix targets $1.2bn valuation in IPO
02.10.Music rights, and the maturing of an alternative asset class
02.10.Apollo-backed Yahoo in talks to divest AOL to Bending Spoons for $1.4bn
02.10.3i Group weighs €1.5bn sale of French IT services firm Evernex
01.10.Permira mulls €3-4bn sale of CNS-focused pharma group Neuraxpharm